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Matrix Stimulates the Proliferation of Human Corneal
Endothelial Cells in Culture
Diane A. Blake, Haini Yu, Danna L. Young, and Delmar R. Caldwell
Purpose. Extracellular matrices were tested for their ability to support the adhesion and prolif-
eration of human corneal endothelial cells.
Methods. Human corneal endothelial cells were plated onto tissue culture dishes coated with
purified fibronectin or a matrix elaborated by cultured bovine corneal endothelial cells. The
presence of human cells in the cultures was confirmed by karyotyping. Cell size at increasing
passage number was analyzed, and cellular response to growth factors was assessed using a
96-well microtiter plate assay.
Results. When tissue culture dishes were coated with fibronectin, the cells attached to the dish
but grew slowly. Human corneal endothelial cells plated onto the matrices elaborated by
bovine corneal endothelial cells attached to the culture dish and grew to fill the flask. At
confluence, the cells had a hexagonal morphology similar to that seen in vivo. Karyotype
analysis showed that the cells were of human and not bovine origin. The time required for
senescence in culture was dependent on the age of the donor cornea. The bovine matrices
enhanced the proliferative response of human corneal endothelial cell cultures to endothelial
cell growth supplement and keratinocyte growth factor. Epidermal growdi factor and hepato-
cyte growth factor stimulated human cell proliferation in a dose-dependent fashion, regardless
of the substratum on which the cells were plated.
Conclusions. The use of substratum elaborated by bovine corneal endothelial cells has proved
useful in the preparation of human endothelial cell cultures from juvenile and adult donors.
The method has been used to establish cultures from more than 50 donors from age 1 day
to 76 years. Invest Ophthalmol Vis Sci. 1997;38:1119-1129.
L he corneal endothelium is essential for the mainte-
nance of normal corneal hydration, thickness, and
transparency.1'2 Despite the critical importance of this
cell layer, a number of studies have shown that human
corneal endothelial cells do not divide at a rate suffi-
cient to maintain a constant density and that endothe-
lial cell density tends to decrease with increasing age
and after ocular insults.3'1 A disorder of the corneal
endothelium caused by disease or trauma can result
in hydration of stromal components and in the onset
of edema. In response to an injury, the endothelial
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cells must migrate into the wound site and reestablish
partial tight junctions before pump function can be
reestablished and corneal clarity restored. In humans,
corneal endothelium appears to heal primarily by en-
largement and migration, not by proliferation of the
endothelial cell layer.4"6
Although tissue culture models could contribute
to the understanding of how human corneal endothe-
lial cells respond to pharmacologic agents, growth fac-
tors, and extracellular matrix molecules during the
wound healing processes, establishing pure long-term
cultures of human corneal endothelial cells from adult
donors has remained a challenging problem. Existing
culture methods require young donors7'8 or special
selection procedures to remove contaminating fibro-
blasts.9 In this study, we report a method for establish-
ing primary cultures of human corneal endothelial
cells free of contaminating fibroblasts. The method
has been used to establish cultures from more than
50 donors from age 1 day to 76 years.
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METHODS
Materials
Human corneas stored for 4 weeks or less in Optisol
GS (Chiron Ophthalmic, Irvine, CA) were generously
provided by the Southern Eye Bank (New Orleans,
LA) and the North Florida Lion's Eye Bank (Jackson-
ville, FL). All corneas had an endothelial cell count
of >2000 cells/mm2 but were excluded from clinical
use because of sepsis, exposure, or donor age younger
than 2 years. Bovine eyes were obtained from a local
slaughterhouse; in the authors' opinion, methods for
securing animal tissue were humane and complied
with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. Tissue culture prod-
ucts, including antibiotics, media, fibronectin, and
balanced salt solutions, were purchased from GIBCO/
BRL (Grand Island, NY). Plasma-derived horse serum
(heparinized) was a product of Cocalico Biologicals
(Reamstoron, PA), and iron-supplemented calf sera
was from Hyclone Laboratories (Logan, UT). Insulin-
transferrin—sodium selenite medium supplement was
purchased from Sigma Chemical (St. Louis, MO), and
ferrous sulfate was added to fill 80% of the transferrin
binding sites. Endothelial cell growth supplement
(ECGS), human recombinant epidermal growth fac-
tor (EGF), hepatocyte growth factor (HGF), or kera-
tinocyte growth factor (KGF) were purchased from
Collaborative Biomedical Products-Becton Dickinson
(Bedford, MA).
Preparation of Matrices From Bovine Corneal
Endothelial Cells
Primary cultures of bovine corneal endothelial (BCE)
cells were prepared according to the method of Mac-
Callum et al.10 The cultures were maintained at 34°C
and 5% carbon dioxide (CO2) in a humidified atmo-
sphere in minimum essential medium supplemented
with 50 fig/m\ gentamicin sulfate and 10% iron-sup-
plemented calf serum. When first-passage cultures had
become confluent (7 to 10 days after subculture), the
cells were stripped from the underlying matrix by
treatment for 5 minutes at 25°C with 0.5% sodium
deoxycholate. After detergent treatment, the matrices
were washed five times with Ca2+, Mg2+-free Earle's
Balanced Salt Solution (EBSS)-5 mM ethylenedi-
aminetetraacetic acid, buffered to pH 7.3 witii 15 mM
Hepes, 10 mM TES, and 10 mM BES (EBSS). Matrices
were used immediately or stored up to 1 month at 4°C
in EBSS containing 1000 U penicillin, 1 mg streptomy-
cin, and 2.5 fig amphotericin B per milliliter. Stored
matrices were rinsed free of antibiotics before they
were used for human cell culture.
Human Cell Culture
The excised human corneas were placed endothelial
cell side up in sterile supporting cups, and the endo-
thelial cell surfaces were rinsed three times with EBSS.
A dilute trypsin solution (18 fig or 180 to 230 BAEE
U/ml in EBSS) was added to the endothelial cell sur-
face, and the corneas were incubated for 30 minutes
at 25°C. Subsequently, the endothelial cell surface was
scraped gently with a rubber spatula constructed from
a tapered piece of silicone surgical rubber 2 to 3 mm
wide, and the dislodged cells were rinsed from the
endothelial cell surface. The trypsin in the dislodged
cells was inactivated by suspension of the cells in me-
dium containing 10% serum. After gentle centrifuga-
tion (5 minutes, 600g), cells from two corneas were
resuspended in 6 ml of minimum essential medium
containing 10% plasma-derived horse serum, 50 fig/
ml gentamicin, 100 U/ml penicillin, 0.1 mg/ml strep-
tomycin, 0.25 fj,g/m\ amphotericin B, 5 fig/m\ insulin,
5 fig/m\ transferrin, 5 ng/ml sodium selenite (human
corneal endothelial [HCE] basal medium), and 150
fig/m\ ECGS and plated in three 35-mm matrix-
coated culture dishes. Cultures were maintained at
37°C and 5% CO2 in a humidified atmosphere. Cul-
ture medium was replaced once a week, and primary
cultures normally grew to confluence in 2 to 4 weeks.
Confluent primary cells were treated with trypsin (180
fig or 1800 BAEE U/ml in EBSS) for 5 minutes, and
the detached cells were rinsed once with culture me-
dium and replated at a split ratio of 1:2 to 1:4 into
matrix-coated dishes. Subcultured cells were fed three
times a week in HCE basal medium containing 15 fig/
ml ECGS. For some experiments, cells were plated
onto tissue culture plastic coated for 2 hours at 37°C
with 100 /xg/ml of bovine fibronectin in serum-free
minimum essential medium.
Chromosome Analysis
Chromosome analysis of HCE cells was carried out as
described by Verma and Babu11 using 50% confluent
first-passage cultures from a 97-day-old female donor.
Cell Sizing
Endothelial cells were established in culture using 10
different corneas from donors of varying ages. After
the primary cultures had reached confluence, they
were split at a 1:2 ratio at 10- to 14-day intervals. At
each passage, an aliquot of the cells was taken for size
analysis. The average cell size was determined using a
Coulter (Hiahleah, FL) Multisizer lie equipped with
a 140-fim aperture. Eight replicates were performed
for every cell sample. The donors were grouped into
those younger than 40 years of age and those older
than 40 years of age, and a two-sample Rest (Systat
6.0 for Windows; SSPS, Chicago, IL) was used to ana-
lyze the data.
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Cell Proliferation in Response to Growth
Factors
Cell proliferation in response to specific growth fac-
tors was determined in 96-well plates using a colori-
metric assay (CellTiter96, Promega, Madison, WI). To
confirm that color formation was proportional to cell
number for HCE cells, varying numbers (1200 to
37,500) of third-passage cells from a 3-month-old do-
nor were suspended in complete culture medium and
added to the wells of a 96-well tissue culture plate.
The cells were allowed to attach to the plate for 1
hour, then 15 fi\ of dye solution was. added and the
cells were allowed to incubate overnight at 37°C. The
assay was completed as described by the manufacturer.
For growth factor studies, second-passage human cor-
neal endothelial cells (7500 cell/well) were plated
onto matrix-coated or uncoated 96-well tissue culture
plates containing HCE basal medium. Growth factors
(e.g., ECGS, EGF, HGF, or KGF) were added at vary-
ing concentrations, and the cells were maintained at
37°C in a humidified atmosphere of 5% CO2. After
18, 41, or 68 hours, 15 /il of dye solution was added,
and the cells were allowed to incubate an additional
2 to 4 hours. Solubilization solution (100 //I) was
added to each well, and the absorbance at 570 nm
was determined after 24 hours as described by the
manufacturer. In control experiments, matrix-coated
or uncoated plates that had received growth factor
but not cells were incubated for 41 or 68 hours at
37°C in a humidified atmosphere of 5% CO2 and sub-
sequently for 2 hours with dye solution. The ab-
sorbance measured on these plates was used to estab-
lish baseline color development in the absence of cells
and to ensure that there was no cell proliferation from
any residual bovine cells that may be present in the
matrix-coated dishes.
RESULTS
Morphology, Karyotype, and Size of Cultured
Cells
In our initial attempts to establish HCE cells in cul-
ture, we tested several types of tissue culture plastic
(Corning-Costar, Falcon Primaria, Nunc), but none
of the surfaces supported adequately the adhesion or
proliferation of HCE cells from the corneas of donors
older than 40 years of age. Fibronectin supported the
adhesion of freshly trypsinized HCE cells, but after a
few days in culture, it became apparent that cells
plated into fibronectin-coated dishes proliferated
rather slowly. In contrast, cells harvested from and
plated onto matrix-coated dishes proliferated more
rapidly. Figures 1A and IB qualitatively show the dif-
ference in proliferative capacity between HCE cells
from a 45-year-old donor plated onto fibronectin (Fig.
1A) or extracellular matrix (Fig. IB). Although the
cultures looked identical 1 to 2 days after the initial
plating, by 23 days of incubation in an identical growth
medium, the cells plated onto matrix clearly had pro-
liferated more rapidly and had a more normal mor-
phology. Figures 1C and ID show that the combina-
tion of culture medium and substratum devised for
these experiments could support the growth of HCE
cells from a variety of donor ages (37 years and 97
days). The matrix-coated culture dishes also allowed
the HCE cells to maintain their proliferative capacity
and morphology through a limited number of subcul-
tures. Figure IE shows that second-passage HCE cells
from a 2-day-old donor maintained an endothelial
morphology after their second subculture onto ma-
trix-coated plates. After an additional trypsinization
and subculture (Fig. IF), these cells are beginning to
show some size differences, indicating the beginnings
of in vitro senescence.
A previously published report12 mentioned (as un-
published results) that when HCE cells were cultured
on the matrix produced by bovine corneal endothe-
lium, the HCE cells thus produced were contaminated
reproducibly with bovine cells. In our experiments,
HCE cells cultured on bovine corneal endothelial cell
matrices showed differences in morphology from bo-
vine cells, including more distinct cell edges and
larger nuclei. In addition, culture dishes that had been
stripped of cells did not show any evidence of viable
cells when tested in a cell proliferation assay (data not
shown). To further rule out the presence of bovine
cells in our cultures, we performed a karyotype analy-
sis of first-passage HCE cells from a 97-day-old female
donor. More than 20 different chromosomal prepara-
tions from cultures prepared with this donor tissue
were examined, and all showed the presence of 46
metaphase chromosomes from a female donor. A rep-
resentative karyotype analysis is shown in Figure 2.
As these experiments progressed, we noted that cells
from older donors appeared to become senescent in
culture more rapidly than did cells from younger do-
nors. We initially attempted to use population doubling
time as a measure of cellular senescence in culture. How-
ever, accurate determination of population doubling
times required more endothelial cells than could be
cultured from a single donor cornea. Cell enlargement
also has been shown to correlate with in vitro senescence
in a variety of cell types.13"17 We therefore used a Coulter
Multisizer to measure cell diameter of human corneal
endothelial cells from various donor ages at increasing
passage numbers, as shown in Figure 3. The 10 donor
corneas used for this analysis were divided into 2 groups,
the first of donors younger than 40 years of age and the
second of donors older than 40 years of age, as shown
by die dotted line in the figure. When the mean cell
diameters from these two groups were compared using
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FIGURE i. Inverted-phase micrographs of human corneal endothelial cells. (A) Primary cul-
tures from a 45-year-old donor 23 days after plating on fibronectin-coated tissue culture
dishes. (B) Primary cells from die same donor 23 days after plating onto matrix-coated
culture dishes. (C) First-passage cells from a 37-year-old donor 10 days after subculture. (D)
First-passage cells from a 97-day-old donor 33 days after subculture. (E) Second-passage cells
from a 2-day-old donor 19 days after subculture. (F) Third-passage cells from a 2-day-old
donor 12 days after subculture. Original magnification, X133.
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FIGURE 2. Karyotype of human corneal endothelial cells
from a 97-day-old donor. Karyotype analysis was performed
as described in Methods.
a two-sample /-test, there was no statistically significant
difference in the diameters of primary and first-passage
cells (P= 0.104 and 0.015, respectively). However, these
two groups did show statistically significant differences
in their diameters at second- and third-passage cells (P
— 0.010 and 0.004, respectively). Other variables in the
experiment, including time between death and tissue
harvest, time of storage before culture, and endothelial
cell count of the donor tissue, were not as statistically
significant in this analysis, as listed in Table 1.
Effects of Growth Factors on Cultured Cells
A 96-well microtiter plate assay was used to determine
cell proliferation in uncoated 96-well tissue culture
plates and in those that had been coated with matrix.
This proliferation assay measured cell number and
viability by the use of a vital dye that living cells have
the ability to transform by way of cellular dehydroge-
nases; dead or dying cells will not transform the dye
and show little or no color development at the ab-
sorbance maximum for the transformed dye. This
assay has been shown to provide data comparable to
that derived by measurement of cell number,1819 cellu-
lar DNA content,20'21 colony-forming units in soft
agar,22'23 3H-thymidine incorporation,24"28 and chro-
mium release.28'29 The absorbances reflect true viabil-
ity and not merely increased adhesion, because the
assay does not require any wash steps that would re-
move unattached cells from the culture dish. In pre-
liminary experiments to confirm that color formation
was proportional to cell number for HCE cells, varying
numbers of cells were allowed to attach to tissue cul-
ture plastic, and color formation was determined, as
shown in Figure 4. Color formation was linear with cell
number when >2400 cells were used in the analysis. In
subsequent analyses, 7500 cells were used for each
data point.
The culture medium used to establish primary
HCE cultures contained very high levels (150 //g/ml)
of ECGS. Because this supplement is expensive, we
wanted to determine whether lower levels would be
sufficient to support proliferation of subcultured hu-
man cells. The data in Figure 5 show that cells plated
on tissue culture plastic were relatively unresponsive
to ECGS at all concentrations tested (see broken lines
in Fig. 5). Cells plated on matrix-coated plates prolifer-
ated in response to ECGS. After 68 hours in culture,
there were significandy more cells present in matrix-
coated plates as compared with those of uncoated con-
trol specimens (compare unbroken lines to broken
FIGURE 3. Effect of passage
number on size of human cor-
neal endothelial cells. Endo-
thelial cells from donors of
vaiying ages were established
in culture as described and
passaged when they reached
confluence (at approximately
10-day intervals). At each pas-
sage, an aliquot of the trypsin-
ized cells was analyzed for cell
diameter using a Coulter
Multizer lie. Values shown are
the mean of eight replicate
analyses ± standard deviation.
^Statistically significant differ-
ence (P <le> 0.010) between
cell diameters in the two
groups of donors.
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TABLE l. Effect of Age, Preservation Conditions, and Endothelial







































































NA = not available.
* The group of donors <40 years of age was compared with the group of donors older than 40 years
of age.
lines in Fig. 5). The cells appeared to proliferate
slightly better in the lowest ECGS concentration tested
(0.1 /ig/ml); however, these data were significant only
at the 95% confidence level. Based on these data,
ECGS concentrations were reduced 10-fold in the cul-
ture medium used for subcultured HCE cells.
Previous reports have indicated that human cor-
neal endothelial cells produce EGF and synthesize
messenger RNA for KGF and HGF.830 All three of
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FIGURE 4. Effect of cell number on color formation in cell
proliferation assay. Third-passage cells from a 3-month-old
donor were plated onto tissue culture plastic. The cells were
allowed to attach to the plate for 1 hour; then 15 y\ of dye
solution was added, and the cells were allowed to incubate
overnight. The assay was completed as described by the man-
ufacturer. A linear regression analysis of the line showed a
nonzero intercept with a correlation coefficient of 0.985.
The values represent the mean of five replicate analyses ±
standard deviation. In some cases, the error in die analysis
is less than the diameter of the point.
proliferation of first-passage HCE cells from young
donors.8 We used the 96-well microtiter plate assay to
determine whether the proliferative response of HCE
cells to these three growth factors was influenced by
culture on matrix-coated plates. The response of HCE
cells to KGF is shown in Figure 6. Cells plated on
tissue culture plastic showed a minimal proliferative
response to KGF over the time course of this experi-
ment (see broken lines in Fig. 5). Cells plated on
matrix-coated plates proliferated in response to KGF,
and there were significantly more cells in the matrix-
coated plates as compared with those of the uncoated
control specimens. Although the lowest concentration
of KGF (0.1 ng/ml) appeared to support the highest
levels of proliferation, the differences in absorbances
were significant only at the 95% confidence level. Ad-
dition of EGF and HGF to HCE cultures stimulated
proliferation in both the matrix-coated and control
tissue culture plates, as shown Figures 7 and 8, respec-
tively. Both growth factors stimulated proliferation in
dose-dependent fashion; the highest concentration of
growth factor tested (100 ng/ml) was most effective
in stimulating cell growth. Absorbance values in EGF-
stimulated cultures more than doubled during the
time course of the experiment (Fig. 7). At any given
level of EGF, cell numbers were higher in the cultures
plated on matrix-coated dishes, indicating that the ma-
trix was providing other factors required by the HCE
cultures. Similar results were observed in the response
of HCE cells to HGF (Fig. 8). The response of HCE
cultures to ECGS, KGF, EGF, and HGF also was deter-
mined with third-passage cells from a 37-year-old do-
nor, with similar results (data not shown).
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FIGURE 5. Effect of endothelial cell growth supplement on
human corneal endothelial cell proliferation. Second-pas-
sage cells from a newborn donor were plated onto tissue
culture plastic or matrix-coated 96-well plates at 7.5 X 103
cells/well and incubated for 0, 18, 41, or 67 hours with
endothelial cell growth supplemental the indicated concen-
trations: A = 100 fj,g/m\; V = 10 jug/ml; 0 = 1 //g/ml; •
= 0.1 fig/ml, (solid lines) Cells plated onto bovine corneal
endothelial extracellular matrix, (dashed lines) Cells plated
onto tissue culture plastic. Viable cells were determined us-
ing the CellTiter96 assay (Promega, Madison, WI); increas-
ing absorbance measures increasing cell number in this
assay. Values shown are the mean of five replicate analyses
± standard deviation.
DISCUSSION
Although several other laboratories have reported the
growth of pure cultures of human corneal endothelial
cells in culture, each of the published methods has
limitations. The method reported by Pistsov et al31
used high concentrations of human serum. The proce-
dures described by Yue et al7 required outgrowth from
tissue explants and high concentrations of chondroi-
tin sulfate in the culture medium. Although the Fal-
con Primaria culture flasks were shown to be superior
to other substratum in these studies, the method was
reported to have a relatively poor success rate with
tissue from donors older than 20 years of age. Subse-
quent studies by these authors32'33 also cited Falcon
Primaria flasks for the culture of corneal endothelial
1125
cells, but these studies again used corneas from donors
younger than 2 years of age. Other investigators who
used the Falcon Primaria plates and the methods de-
scribed by Yue et al7 to culture endothelial cells from
older donors (older than 40 years of age) reported
that cultures maintained for more than 2 weeks on
these plates were characterized by a high proportion
of large, irregular, vacuolated cells that they character-
ized as senescent.30 The morphology of the cells from
these cultures30 was similar to that of cells from a 45-
year-old donor cultured on fibronectin-coated plates
(Fig. 1A). The procedure of Engelmann and Friedl9
used enzymatic treatment to release endothelial cells
without mechanical trauma. However, this extensive
proteolysis also released large quantities of stroma fi-
broblasts from donor corneas, and the fibroblasts
overgrew the endothelial cells after 4 to 5 days in pri-
mary culture. A special culture medium devoid of L-
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FIGURE 6. Effect of keratinocyte growth factor on human
corneal endothelial cell proliferation. Third-passage cells
from a newborn donor were plated onto tissue culture plas-
tic or matrix-coated 96-well plates at 7.5 X 10s cells/well
and incubated for 0, 18, 42, or 7 hours with keratinocyte
growth factor at the indicated concentrations: A = 100 / /g/
ml; V = 10/ig/ml; 0 = 1 /Ltg/ml; D = 0.1 £tg/ml. (solid lines)
Cells plated onto bovine corneal endothelial extracellular
matrix, (dashed lines) Cells plated onto tissue culture plastic.
Values shown are the mean of five replicate analyses ± stan-
dard deviation.
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FIGURE 7. Effect of epidermal growth factor on human cor-
neal endothelial cell proliferation. Second-passage cells
from a newborn donor were plated onto tissue culture plas-
tic or matrix-coated 96-well plates at 7.5 X 103 cells/well
and incubated for 0, 18, 41, or 67 hours with epidermal
growth factor at the indicated concentrations: A = 100 fj,g/
ml; V = 10 /zg/ml; 0 = 1 /ig/ml; • = 0.1 //g/ml. (solid lines)
Cells plated onto bovine corneal endothelial extracellular
matrix, (dashed lines) Cells plated onto tissue culture plastic.
Values shown are the mean of five replicate analyses ± stan-
dard deviation.
to inhibit fibroblast proliferation in primary cultures,
and serum supplements were treated with sequential
dialysis and ion exchange chromatography to remove
fibroblast growth factor, platelet-derived growth fac-
tor, and L-valine. The human corneal endothelial cell
cultures were maintained in this medium through
four to six subcultures before selective pressure was
removed.
In the current study, we used a reduced incubation
time (30 minutes instead of 90 minutes) and a trypsin
solution approximately 50-fold less concentrated than
that recommended by Engelmann et al"1 to release the
endothelial cells from Descemet's membrane. Gentle
scraping of the endothelial cell surface released cells in
small clumps and sheets. This gentle proteolysis released
few stromal fibroblasts from the donor corneas. The
growth of these fibroblasts was inhibited in culture by
replacing the serum in the culture medium with plasma.
Plasma has low concentrations of platelet-derived growth
factor, one of the primary growth factors required for
fibroblast proliferation.34 The culture medium used in
our studies was a minor modification of that described
by Grant and Guay35 for the culture of human retinal
endothelial cells. This medium was supplemented with
ECGS, which has been reported by several groups to stim-
ulate the proliferation of human corneal endothelial
cells.7"9'12
The substratum on which human cultures are
maintained was of major importance in both mito-
genic potential and morphology of human corneal
endothelial cells. Various extracellular matrix mole-
cules, including fibronectin,9 gelatin,12'36 laminin,12 a
combination of laminin and chondroitin sulfate,12 and
chondroitin sulfate,12 have been reported to stimulate
the adhesion-proliferation of HCE cells in culture.
By our accounts, each of these was inferior to the
matrix elaborated by bovine corneal endothelial cells.
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FIGURE 8. Effect of hepatocyte growth factor on human cor-
neal endothelial cell proliferation. Second-passage cells
from a newborn donor were plated onto tissue culture plas-
tic or matrix-coated 96-well plates at 7.5 X 103 cells/well and
incubated for 0, 18, 41, or 67 hours with hepatocyte growth
factor at the indicated concentrations: A = 100 /ng/ml; V
= 10 / x g / m l ; 0 = 1 fjLg/ml; • = 0 .1 fxg/ml. (solid lines)
Cells plated onto bovine corneal endothelial extracellular
matrix, (dashed lines) Cells plated onto tissue culture plastic.
Values shown are the mean of five replicate analyses ± stan-
dard deviation.
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trypsinized cells, and in contrast to fibronectin, which
also supported adhesion, the bovine corneal endothe-
lial cell substratum also stimulated proliferation of the
human cultures to greater extent than any other com-
bination of substratum and growth factor we have
tested to date.
The complex extracellular matrix elaborated by
bovine corneal endothelial cells has been used by a
number of investigators to support the growth of
fastidious cells in culture. Gospodarowicz and co-
workers37"40 reported that costal chondrocytes cul-
tured on this matrix retained their ability to synthe-
size a cartilage-like extracellular matrix. This group
also has used the BCE matrix to support the prolifer-
ation of bovine granulosa, adrenal cortex, human
tumor, and vascular endothelial cells in culture. The
BCE matrices have been used by other researchers
to support the culture of human ovarian and endo-
metrial carcinoma cells, human lung type II cells,
and pancreatic islet cells.41"43
In contrast to previous literature reports12 that a
BCE substratum will result in contamination of the
human cultures with bovine cells, we detected no such
contamination in our cultures. When karyotype analy-
sis was performed on first-passage cultures from a 96-
day-old female donor, both the chromosome number
and the banding patterns were consistent with a tissue
of human origin. Human cells have 46 chromosomes,
bovine cells have 60, and the chromosomes have a
pattern of banding distinct from that observed in hu-
mans.44'45 All chromosomes (20 sets were examined)
from cultures derived from this donor were of human
origin and of the correct gender for the donor tissue
(female). Any bovine contamination in these cultures
would therefore be aX. <5%. The relatively harsh con-
ditions used to prepared the matrices from the bovine
cultures (0.5% sodium deoxycholate in water) com-
pletely removes all cells from the matrices in less than
2 minutes' time. These matrices normally are stored
for at least a week at 4°C in balanced salt solutions. It
is extremely unlikely that any bovine cells could sur-
vive such stringent preparation and storage condi-
tions. In addition, matrix-coated 96-well plates did not
have the ability to transform the vital dye used in the
96-well microplate cell proliferation assay; these find-
ings suggest that no bovine cells survived the detergent
extraction procedure.
In the growth factor studies, we observed some
suppression of color formation at the 20-hour time-
point for cells treated with ECGF, KGF, and EGF. This
difference in color formation during the first 20 hours
of culture most likely represented a difference in plat-
ing efficiencies in the matrix-coated versus plastic
dishes rather than a suppression of growth, because
the cells in the matrix-coated dishes soon outstripped
their counterparts on plastic to achieve higher cell
densities. Although KGF and ECGS have been re-
ported to be mitogens for HCE cells,89 in the current
study, these growth factors had little effect unless the
cells were cultured on matrix-coated plates. Endothe-
lial growth factor and HGF were mitogenic for HCE
cells grown on either tissue culture plastic or matrix-
coated plates, as has been reported previously.8 In the
previous study, however, HCE cells responded maxi-
mally to these two growth factors at a concentration
of 25 ng/ml, whereas in the current study, the cells
continued to respond at concentrations up to 100 ng/
ml. This apparent inconsistency may be because of
the nature of the assay used to monitor cell prolifera-
tion. In previous studies, cells were cultured for several
days in the presence of the test substance; in the stud-
ies reported herein, the cells were in contact with
growth factor for a much shorter period, 18 to 68
hours.
It also is possible, however, that culture on this
complex extracellular matrix could be modulating cel-
lular response to growth factors. The BCE matrices
have been shown to contain basic fibroblast growth
factor,46'47 proteoglycans48'49 types I, III, IV, V, and VIII
collagens,50'51 fibronectin,5253 laminin,53'54 thrombos-
pondin,53 and tissue- and urokinase-type plasminogen
activators.55 Previous studies have shown that growth
factors often work synergistically; the presence of one
growth factor can change the response to another
growth factor.56 In addition, extracellular matrix mole-
cules and proteolytic fragments from extracellular ma-
trix molecules have been shown to influence cellular
response to growth factors in a variety of cell types,
including bovine corneal endothelial cells.38'57 It is
therefore not surprising that we have observed some
differences in concentration-dependent responses to
growth factors in our experimental system as com-
pared with those of previous reports.
The ready availability of HCE cells in culture will
allow us to more easily define the roles that growth
factors and extracellular matrix molecules play in the
HCE proliferation and migration. Experiments are in
progress to determine which of these substratum com-
ponents are most important for the proliferation and
migration of human corneal endothelial cells.
Key Words
cell proliferation, corneal endothelial cells, extracellular ma-
trix, growth factors, tissue culture
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